The changes of the tissue plasminogen activator levels in the endometrium during antifibrinolytic therapy.
D000293:Adolescent; D000328:Adult; D000614:Aminocaproates / Q000494:pharmacology / Q000627:therapeutic use; D000933:Antifibrinolytic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D004717:Endometrium / Q000032:analysis* / Q000187:drug effects; D005260:Female; D005342:Fibrinolysis / Q000187:drug effects; D006801:Humans; D008796:Metrorrhagia / Q000188:drug therapy; D008875:Middle Aged; D009214:Myoma / Q000150:complications; D010958:Plasminogen / Q000096:biosynthesis*; D011247:Pregnancy; D014592:Uterine Hemorrhage / Q000150:complications / Q000188:drug therapy; D014594:Uterine Neoplasms / Q000150:complications
D000614:Aminocaproates; D000933:Antifibrinolytic Agents; D010958:Plasminogen